Skip to main content
Eric Topol

Eric Topol

American cardiologist and scientistWikipedia

Search complete. 29 mentions across 23 episodes found for "Eric Topol".

Nov 20, 2026

John AyersGUEST
67:16
You know, the journals, editorials wrote another thing on it.
John AyersGUEST
67:19
Like, what are you talking about? You know, Eric Topol's talking about it.
John AyersGUEST
67:23
Like, this is an important article.
John AyersGUEST
67:24
No, it didn't have those effects.
Kristin Kostick-QuenetGUEST
18:31
I do, absolutely.
Kristin Kostick-QuenetGUEST
18:32
Dr. Eric Topol wrote this book called Deep Medicine, which you're probably familiar with, and that was probably, what, 10, 15 years ago by now? But he anticipated that the more widespread use of AI would have really beneficial impacts on the clinician encounter because you're not sitting there and typing into your computer.
Kristin Kostick-QuenetGUEST
18:49
It takes all those tasks away that we can kind of delegate to computational tools so that we can focus on the more human elements of care.
Kristin Kostick-QuenetGUEST
18:56
I don't know the degree to which that's happening yet, but I know that's something that physicians have wanted for a long time.
Tom MarronGUEST
34:01
That, you know, a lot of people, the last 30 years of their life is terrible because they have all these health complications and they're immobile and at home and in pain.
Tom MarronGUEST
34:08
And the idea of healthspan is really to keep people healthy for longer so that, you know, I think Eric Topol said, so basically your body falls apart.
Tom MarronGUEST
34:16
all at the same time in the last six months of your life.
Tom MarronGUEST
34:18
And so your kidneys, heart, and brain all fail really quickly and you die, as opposed to dying over the course of 30 years.
Jo ChikweGUEST
16:23
So a lot to dive into there.
Jo ChikweGUEST
16:25
It was phenomenal to have keynote speakers like Eric Topol, who I feel really set the sort of tone between the science and future.
Jo ChikweGUEST
16:35
And speakers like Joshua Angrist, the Nobel laureate.
Jo ChikweGUEST
16:38
Two phenomenal sessions, how to write like a Nobel laureate.
Saul NewmanGUEST
56:22
got funded.
Saul NewmanGUEST
56:24
And Professor Alstad completely by coincidence announced that a few months later that he had a partnership with Blue Zones uh and that had been put together by Olshansky this guy that said oh what's a conflict right yeah uh so that was you know this is amazing enough these are sort of big names in the field but no one else is going to recognize them uh but then another curious event overtook me because I had The most scientist in the world is called Eric Topol.
Saul NewmanGUEST
56:59
Dr. Eric Topol is famous in America as far as
Ken BerryHOST
57:02
science can make you famous.
Saul NewmanGUEST
57:05
What did Dr. Topol do? Well, he took a sudden interest in blue zones and started emailing them to me.
Simon WhistlerNARRATOR
13:19
You don't try to fix a problem that doesn't exist, do you? Outside the walls of Merck, the medical community wasn't entirely asleep.
Simon WhistlerNARRATOR
13:26
There were watchdogs who saw the Vigor data and… In 2001, a team led by Dr. Eric Topol at the prestigious Cleveland Clinic published a study in the Journal of American Medical Association.
Simon WhistlerNARRATOR
13:38
They looked at the available data and linked Vioxx to a significant risk of heart attack and stroke.
Simon WhistlerNARRATOR
13:43
They challenged the naproxen hypothesis directly.
Simon WhistlerNARRATOR
18:37
There were doctors who weren't on the payroll.
Simon WhistlerNARRATOR
18:39
There were researchers who looked at the data and refused to be silent.
Simon WhistlerNARRATOR
18:44
Men like Dr. Garkapol Singh at Stanford or Dr. Eric Topol at the Cleveland Clinic.
Simon WhistlerNARRATOR
18:50
When these independent experts voiced alarm, Merck didn't invite them for a debate.
Mark HymanHOST
15:54
right so how about this how about
George SapiroGUEST
15:57
curing cardiovascular disease I gave a talk two years ago on is there a cure for cardiovascular disease and it turns out a lot of the research and some was done at the Cleveland Clinic I know you're there by Eric Topol and and he did a lot of stuff with PCS k9 inhibitors and vaccines so if we can basically start giving a vaccine to children when they're five years old, along with the measles, mumps, rubella vaccine, or polio vaccine, you give them a PCS2 canine inhibitor vaccine and follow them.
George SapiroGUEST
16:29
Now you may not develop cholesterol plaques.
George SapiroGUEST
16:31
You may not need to even worry about statins.
John MandrolaHOST
15:10
Now, the results led to a number of prominent people in cardiology posting it on social media with screenshots of the study's Kaplan-Meier curve and saying, we've been doing it wrong with RV pacing.
John MandrolaHOST
15:22
This even included Dr. Eric Topol, said we're doing it wrong and we have a new way.
John MandrolaHOST
15:27
And look, no one is a bigger conduction system pacing enthusiast than me.
John MandrolaHOST
15:32
I was an early adopter of His Bundle Pacing in 2016, and I run around the hospital showing anybody who was interested these beautiful EKGs from His and Left Bundle Branch Pacing.
John KobyltHOST
30:28
One official complained that Bakaria took too passive a role.
John KobyltHOST
30:34
A prominent COVID researcher, Dr. Eric Topol, said Bakaria was like a ghost.
John KobyltHOST
30:40
and demanded that he step up or step aside.
John KobyltHOST
30:44
So the White House worked around Bakaria, transferring pandemic management to somebody else.
Michael DaviesGUEST
41:46
Because they actually want to be working with patients and listening to patients and being able to look them in the eye.
Michael DaviesGUEST
41:52
This was a vision that Eric Topol of Scripps had a few years ago when he was laying that out.
Michael DaviesGUEST
41:57
And it's finally coming to fruition.
Michael DaviesGUEST
42:00
And it's giving people who are scarce, highly trained resources back their time.

13 more episodes mention Eric Topol.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.